The medical research council PT1 trial in essential thrombocythemia.

Bibliografische gegevens
Hoofdauteurs:	Green, A, Campbell, P, Buck, G, Wheatley, K, East, C, Bareford, D, Wilkins, B, Van der Walt, J, Reilly, J, Harrison, C
Formaat:	Conference item
Gepubliceerd in:	2004

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia.
door: Harrison, C, et al.
Gepubliceerd in: (2005)

Reticulin accumulation in essential thrombocythemia: prognostic significance and relationship to therapy.
door: Campbell, P, et al.
Gepubliceerd in: (2009)

Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.
door: Wilkins, B, et al.
Gepubliceerd in: (2008)

Clinical significance of MPL mutations in essential thrombocythemia: Analysis of the PT-1 cohort.
door: Beer, P, et al.
Gepubliceerd in: (2007)

Bone Marrow Fibrosis and Diagnosis of Essential Thrombocythemia Reply to J. Thiele et al
door: Campbell, P, et al.
Gepubliceerd in: (2009)

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort.
door: Campbell, P, et al.
Gepubliceerd in: (2012)

JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera.
door: Green, A, et al.
Gepubliceerd in: (2005)

Neuromyotonia in association with essential thrombocythemia.
door: Benito-León, J, et al.
Gepubliceerd in: (2000)

Impact of platelet glycoprotein polymorphisms upon clinical events in essential thrombocythaemia patients enrolled in the PT1 trial
door: Robinson, SE, et al.
Gepubliceerd in: (2007)

Classification of Philadelphia Translocation-Negative Myeloproliferative Neoplasms: Its Impact on Data From Clinical Trials Reply
door: Campbell, P, et al.
Gepubliceerd in: (2009)

Longitudinal mutational analysis in hydroxycarbamide-resistant/intolerant essential thrombocythemia treated on the majic-ET study
door: O'Sullivan, J, et al.
Gepubliceerd in: (2018)

MPL S505C enhances driver mutations at W515 in essential thrombocythemia
door: Varghese, LN, et al.
Gepubliceerd in: (2021)

MPL mutations in myeloproliferative disorders: analysis of the PT-1 cohort.
door: Beer, P, et al.
Gepubliceerd in: (2008)

Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.
door: Campbell, P, et al.
Gepubliceerd in: (2005)

Adverse impact of bone marrow transplantation on quality of life in acute myeloid leukaemia patients; analysis of the UK Medical Research Council AML 10 Trial.
door: Watson, M, et al.
Gepubliceerd in: (2004)

The presence of the factor V Leiden and the prothrombin G20210A polymorphism does not appear to influence the risk of thrombosis in essential thrombocythaernia: results of a nested case control study
door: Robinson, S, et al.
Gepubliceerd in: (2008)

The 1944 patulin trial of the British Medical Research Council.
door: Clarke, M
Gepubliceerd in: (2006)

Correlation between treatment outcomes, baseline characteristics and molecular responses in the Majic study which compared Ruxolitinib to best available therapy in essential thrombocythemia
door: Harrison, C, et al.
Gepubliceerd in: (2016)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
door: Eden, O, et al.
Gepubliceerd in: (1991)

Outcome for children with relapsed acute myeloid leukaemia following initial therapy in the Medical Research Council (MRC) AML 10 trial. MRC Childhood Leukaemia Working Party.
door: Webb, D, et al.
Gepubliceerd in: (1999)

The Medical Research Council trials in adult acute lymphocytic leukemia.
door: Durrant, I, et al.
Gepubliceerd in: (2000)

Relationships between age at diagnosis, clinical features and outcome of therapy in children treated in the Medical Research Council trials for acute myeloid leukemia AML 10 and 12.
door: Webb, D, et al.
Gepubliceerd in: (2000)

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.
door: Webb, D, et al.
Gepubliceerd in: (2001)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
door: Chessells, J, et al.
Gepubliceerd in: (1995)

Impact of JAK2V617F mutational on haematologic features in Sudanese patients with essential thrombocythemia and thrombotic risk assessment
door: Elbager, Sahar G., et al.
Gepubliceerd in: (2020)

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
door: Grimwade, D, et al.
Gepubliceerd in: (2001)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
door: Grimwade, D, et al.
Gepubliceerd in: (1998)

The end of the Medical Council of India
door: Jha, V
Gepubliceerd in: (2018)

Immediate versus deferred treatment for advanced prostatic cancer: Initial results of the Medical Research Council trial
door: Adib, R, et al.
Gepubliceerd in: (1997)

Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
door: Richards, S, et al.
Gepubliceerd in: (1998)

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
door: Durrant, I, et al.
Gepubliceerd in: (1993)

Knock-in of murine Calr del52 induces essential thrombocythemia with slow-rising dominance in mice and reveals key role of Calr exon 9 in cardiac development.
door: Balligand, T, et al.
Gepubliceerd in: (2019)

Targeted Sequencing of Sorted Peripheral Blood Cells Reveals Novel Germline and Somatic Variants in the Polymorphonuclear and Mononuclear Cells of Patients with Essential Thrombocythemia, Polycythemia Vera and Primary Myelofibrosis
door: Wong, C.L., et al.
Gepubliceerd in: (2015)

Karyotype and prognosis in childhood acute lymphoblastic leukemia (ALL) in the UK medical research council (MRC) ALL97 trial.
door: Moorman, A, et al.
Gepubliceerd in: (2003)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
door: Eden, O, et al.
Gepubliceerd in: (2000)

Hydroxycarbamide plus Aspirin vs Aspirin alone in patients with essential Thrombocythaemia aged 40-59 years without high-risk features
door: Buck, G, et al.
Gepubliceerd in: (2018)

CHILDREN UNDER 2 YEARS TREATED ACCORDING TO THE MEDICAL-RESEARCH-COUNCIL UKALL-VIII STUDY AND TRIAL 1980-1984 (ON BEHALF OF THE MEDICAL-RESEARCH-COUNCIL WORKING PARTY ON LEUKEMIA IN CHILDHOOD)
door: Eden, O, et al.
Gepubliceerd in: (1992)

Intensification of treatment for adults with acute lymphoblastic leukaemia: results of U.K. Medical Research Council randomized trial UKALL XA. Medical Research Council Working Party on Leukaemia in Adults.
door: Durrant, I, et al.
Gepubliceerd in: (1997)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
door: Hann, I, et al.
Gepubliceerd in: (1998)

Preliminary results of the UK Medical Research Council trial in chronic lymphocytic leukaemia - CLL3
door: Catovsky, D, et al.
Gepubliceerd in: (1998)

The medical research council PT1 trial in essential thrombocythemia.

Gelijkaardige items

Gelijkaardige items